Molecular portraits and trastuzumab responsiveness of estrogen receptor-positive, progesterone receptor-positive, and HER2-positive breast cancer.

Theranostics · 2019 · PMC6691389 · PMID 31410192

Europe PMC DOI

hedged sentence

0.1060

closest p · 2.1× alpha

0.1060

boldest claim

The sentences

did not reach statistical significanceP = 0.106not close (p > 0.1)

We observed a tendency of better DFS and OS in TPBCs of the luminal A subtype than in those of the other subtypes, but the difference did not reach statistical significance due to the small sample size (DFS: log-rank P = 0.106, OS: log-rank P = 0.088; Figure S1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.